Stay updated on Biogen Press Releases
Sign up to get notified when there's something new on the Biogen Press Releases page.

Latest updates to the Biogen Press Releases page
- Check6 days agoChange DetectedNew 2026 news entries were added, including Biogen to Present at the 44th Annual J.P. Morgan Healthcare Conference and the LEQEMBI submission accepted in China, along with a 2026 copyright line, while older 2025 items were removed.SummaryDifference8%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedTwo new items were added to Biogen News on December 22, 2025: 'Biogen Issues Statement in Response to the Passing of Charles Weissmann, MD, Ph.D., Co-Founder of Biogen' and 'The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extension in SOD1-ALS'. Two November 2025 items were removed: 'Biogen to Highlight New Lecanemab Data and Scientific Advances at the 18th Clinical Trials on Alzheimer’s Disease Conference' and 'Biogen to Participate in Upcoming Investor Conferences'.SummaryDifference4%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe News page adds four December 2025 press releases and removes three older items from the listing.SummaryDifference4%

- Check42 days agoChange DetectedThree new Biogen News releases were added (Dec 1, 2025; Nov 27, 2025; Nov 25, 2025) and three older items (Nov 3–4, 2025 and Oct 30, 2025) were removed from the listing.SummaryDifference4%

- Check49 days agoChange DetectedAdded three new Biogen news items for November 2025, including the Dayra Therapeutics collaboration and Lecanemab data updates. Removed several October 2025 releases from the News listing.SummaryDifference4%

- Check56 days agoChange DetectedAdded several November 2025 Biogen news releases including Dravet syndrome data, CHMP opinion for nusinersen, the Alcyone Therapeutics acquisition, and LEQEMBI IV maintenance dosing approval in the UK. Removed older October 2025 press releases such as the TIME Best Inventions acknowledgment, additional data from the CNS presentation, a donation, and LEQEMBI autoinjector U.S. availability.SummaryDifference4%

Stay in the know with updates to Biogen Press Releases
Enter your email address, and we'll notify you when there's something new on the Biogen Press Releases page.